Opioid use and misuse: health impact, prevalence, correlates and interventions

References

• Abrams, D. I., Couey, P., Shade, S. B., Kelly, M. E., & Benowitz, N. L. (2011). Cannabinoid–opioid interaction in chronic pain. Clinical Pharmacology & Therapeutics, 90, 844–851. doi:10.1038/clpt.2011.188
   PubMed Web of Science ®Google Scholar
• Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., & Reda, H. (2007). Cannabis in painful HIV-associated sensory neuropathy—A randomized placebo-controlled trial. Neurology, 68, 515–521. doi:10.1212/01.wnl.0000253187.66183.9c
   PubMed Web of Science ®Google Scholar
• Ahmad, F. B., Rossen L. M., Spencer M. R, Warner M., & Sutton P. (2018). Provisional drug overdose death counts. National Center for Health Statistics. Retrived from: https://www.cdc.gov/nchs/nvss/vsrr/drugoverdose-data.htm
   Google Scholar
• Alexander, G. C., Kruszewski, S. P., & Webster, D. W. (2012). Rethinking opioid prescribing to protect patient safety and public health. JAMA, 308, 1865–1866. doi:10.1001/jama.2012.14282
   PubMed Web of Science ®Google Scholar
• Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011). Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. The Cochrane Database of Systematic Reviews, 9.
   Google Scholar
• American Cancer Society Cancer Action Network (ACS CAN). (2018). Retrieved from https://www.acscan.org/sites/default/files/ACS%20CAN%20PQLC%20Opioid%20Research%20Project%20Key%20Findings%20Summary%20Memo%20FINAL.pdf
   Google Scholar
• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-V- TR (5th ed.). Arlington, VA: American Psychiatric Publishing.
   Google Scholar
• Arreola, S., Bluthenthal, R. N., Wenger, L., Chu, D., Thing, J., & Kral, A. H. (2014). Characteristics of people who initiate injection drug use later in life. Drug Alcohol Depend, 138, 244–250. doi:10.1016/j.drugalcdep.2014.02.026
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). (2002). 2001 National drug strategy household survey: First RESULTS (AIHW cat. no. PHE 35. Drug Statistics Series No. 9). Canberra: AIHW. Retrieved from http://www.aihw.gov.au/publication-detail/?id= 6442467340
   Google Scholar
• Back, S. E., Payne, R. L., Simpson, A. N., & Brady, K. T. (2010). Gender and prescription opioids: Findings from the National Survey on Drug Use and Health. Addictive Behaviours, 35, 1001–1007. doi:10.1016/j.addbeh.2010.06.018
   PubMed Web of Science ®Google Scholar
• Bailey, J. E., Campagna, E., & Dart, R. C. (2009). The underrecognized toll of prescription opioid abuse on young children. Annals of Emergency Medicine, 53, 419–424. doi:10.1016/j.annemergmed.2008.07.015
   PubMed Web of Science ®Google Scholar
• Baldacchino, A., Balfour, D. J. K., Passetti, F., Humphris, G., & Matthews, K. (2012). Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis. Neuroscience & Biobehavioral Reviews, 36, 2056–2068. doi:10.1016/j.neubiorev.2012.06.006
   PubMed Web of Science ®Google Scholar
• Bell, T., Annunziata, K., & Leslie, J. B. (2009). Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: Findings from the National Health and Wellness Survey. Journal of Opioid Management, 5, 137–144.
   PubMedGoogle Scholar
• Ben Amar, M. (2006). Cannabinoids in medicine: A review of their therapeutic potential. Journal of Ethnopharmacology, 105, 1–25.
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N., Wenger, L., Chu, D., Bourgois, P., & Kral, A. H. (2017). Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California. Drug and Alcohol Dependence, 175, 210–218. doi:10.1016/j.drugalcdep.2017.04.001 doi:10.1016/j.drugalcdep.2017.04.001
   PubMed Web of Science ®Google Scholar
• Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016). Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. The Journal of Pain, 17, 739–744. doi:10.1016/j.jpain.2016.03.002
   PubMed Web of Science ®Google Scholar
• Bohnert, A. S., Guy, G. P., Jr., & Losby, J. L. (2018). Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention's 2016 opioid guideline. Annals of Internal Medicine, 169, 367–375. doi:10.7326/M18-1243
   PubMed Web of Science ®Google Scholar
• Boscarino, J. A., Rukstalis, M., Hoffman, S. N., Han, J. J., Erlich, P. M., Gerhard, G. S., & Stewart, W. F. (2010). Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction, 105, 1776–1782. doi:10.1111/j.1360-0443.2010.03052.x
   PubMed Web of Science ®Google Scholar
• Bryant, J., & Treloar, C. (2006). Risk practices and other characteristics of injecting drug users who obtain injecting equipment from pharmacies and personal networks. International Journal of Drug Policy, 17, 418–424. doi:10.1016/j.drugpo.2006.07.004
   Web of Science ®Google Scholar
• Busch, A. J., Barber, K. A., Overend, T. J., Peloso, P. M. J., & Schachter, C. L. (2007). Exercise for treating fibromyalgia syndrome. The Cochrane Database of Systematic Reviews (4).
   Google Scholar
• CDC. (2012). Community-based opioid overdose prevention programs providing Naloxone – United States, 2010. MMWR: Morbidity and Mortality Weekly Report, 61, 101–105.
   PubMedGoogle Scholar
• Cicero, T. J., Dart, R. C., Inciardi, J. A., Woody, G. E., Schnoll, S., & Muñoz, A. (2007). The development of a comprehensive risk-management program for prescription opioid analgesics: Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®). Pain Medicine, 8, 157–170. doi:10.1111/j.1526-4637.2006.00259.x
   PubMed Web of Science ®Google Scholar
• Cicero, T. J., & Ellis, M. S. (2015). Abuse-deterrent formulations and the prescription opioid abuse epidemic in the united states: Lessons learned from oxycontin. JAMA Psychiatry, 72, 424–430. doi:10.1001/jamapsychiatry.2014.3043
   PubMed Web of Science ®Google Scholar
• Cichewicz, D. L., & Welch, S. P. (2003). Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol. Journal of Pharmacology and Experimental Therapeutics, 305, 812–817. doi:10.1124/jpet.102.046870
   PubMed Web of Science ®Google Scholar
• Coleman, K., Austin, B. T., Brach, C., & Wagner, E. H. (2009). Evidence on the chronic care model in the new millennium. Health Aff (Millwood), 28, 75–85. doi:10.1377/hlthaff.28.1.75
   PubMed Web of Science ®Google Scholar
• INCB. (2016). Comments on the reported statistics on narcotic drugs. International Narcotics Control Board. Retrieved from https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2017/7_Part_2_comments_E.pdf
   Google Scholar
• Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. J., … Burls, A. (2007). Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation. In NIHR Health Technology Assessment programme: Executive Summaries. NIHR Journals Library.
   Google Scholar
• Connors, G. J. (1998). Overview of Project MATCH. The Addictions Newsletter, 5, 4–5.
   Google Scholar
• Conroy, E., Degenhardt, L., Mattick, R. P., & Nelson, E. C. (2009). Child maltreatment as a risk factor for opioid dependence: Comparison of family characteristics and type and severity of child maltreatment with a matched control group. Child Abuse & Neglect, 33, 343–352. doi:10.1016/j.chiabu.2008.09.009
   PubMed Web of Science ®Google Scholar
• Crofts, N., Louie, R., Rosenthal, D., & Jolley, D. (1996). The first hit: Circumstances surrounding initiation into injecting. Addiction, 91, 1187–1196. doi:10.1046/j.1360-0443.1996.918118710.x
   PubMed Web of Science ®Google Scholar
• D’onofrio, G., O’connor, P. G., Pantalon, M. V., Chawarski, M. C., Busch, S. H., Owens, P. H., … Fiellin, D. A. (2015). Emergency department–initiated buprenorphine/naloxone treatment for opioid dependence: A randomized clinical trial. JAMA, 313, 1636–1644. doi:10.1001/jama.2015.3474
   PubMed Web of Science ®Google Scholar
• Darke, S., Ross, J., & Teesson, M. (2007). The Australian Treatment Outcome Study (ATOS): What have we learnt about treatment for heroin dependence? Drug and Alcohol Review, 26(1), 49–54. doi:10.1080/09595230601036986
   PubMed Web of Science ®Google Scholar
• Darke, S., Williamson, A., Ross, J., Teesson, M., & Lynskey, M. (2004). Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Drug & Alcohol Dependence, 74(1), 77–83. doi:10.1016/j.drugalcdep.2003.12.002
   PubMed Web of Science ®Google Scholar
• Delgado, M. K., Huang, Y., Meisel, Z., Hennessy, S., Yokell, M., Polsky, D., & Perrone, J. (2018). National variation in opioid prescribing and risk of prolonged use for opioid-naive patients treated in the emergency department for ankle sprains. Annals of Emergency Medicine, 72(4), 389–400.
   PubMed Web of Science ®Google Scholar
• Dijkgraaf, M. G., van der Zanden, B. P., de Borgie, C. A., Blanken, P., van Ree, J. M., & van den Brink, W. (2005). Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ, 330, 1297. doi:10.1136/bmj.330.7503.1297
   PubMed Web of Science ®Google Scholar
• Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA, 315, 1624–1645. doi:10.1001/jama.2016.1464
   PubMed Web of Science ®Google Scholar
• Dowell, D., Noonan, R. K., & Houry, D. (2017). Underlying factors in drug overdose deaths. JAMA, 318, 2295–2296. doi:10.1001/jama.2017.15971
   PubMed Web of Science ®Google Scholar
• Draus, P. J., & Carlson, R. G. (2006). Needles in the haystacks: The social context of initiation to heroin injection in rural Ohio. Substance Use & Misuse , 41, 1111–1124. doi:10.1080/10826080500411577
   PubMed Web of Science ®Google Scholar
• FDA. (2018). Timeline of selected FDA activities and significant events addressing opioid misuse and abuse. US Food and Drug Administration. Retrieved fromhttps://fas.org/sgp/crs/misc/R45218.pdf
   Google Scholar
• Feng, C., DeBeck, K., Kerr, T., Mathias, S., Montaner, J., & Wood, E. (2013). Homelessness independently predicts injection drug use initiation among street-involved youth in a Canadian setting. Journal of Adolescent Health, 52, 499–501. doi:10.1016/j.jadohealth.2012.07.011
   PubMed Web of Science ®Google Scholar
• Fishbain, D. A., Cole, B., Lewis, J., Rosomoff, H. L., & Rosomoff, R. S. (2007). What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Medicine, 9, 444–459. doi:10.1111/j.1526-4637.2007.00370.x
   Web of Science ®Google Scholar
• Fitzgerald, J. L., Louie, R., Rosenthal, D., & Crofts, N. (1999). The meaning of the rush for initiates to injecting drug use. Contemporary Drug Problems, 26, 481–504. doi:10.1177/009145099902600307
   Google Scholar
• Food and Drug Administration. (2009). Summary minutes. Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee and Drug Safety & Risk Management Advisory Committee. Accessed October 20, 2018.https://www.federalregister.gov/documents/2009/04/24/E9-9380/joint-meeting-of-the-drug-safety-and-risk-management-advisory-committee-nonprescription-drugshttps://www.federalregister.gov/d/E9-9380
   Google Scholar
• Fransen, M., McConnell, S., Harmer, A. R., Van der Esch, M., Simic, M., & Bennell, K. L. (2015). Exercise for osteoarthritis of the knee: A Cochrane systematic review. British Journal of Sports Medicine, 49, 1554–1557.
   PubMed Web of Science ®Google Scholar
• Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., … Ling, W. (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine, 349, 949–958. doi:10.1056/NEJMoa022164
   PubMed Web of Science ®Google Scholar
• Gable, R. S. (2006). Acute toxicity of drugs versus regulatory status. In J. M. Fish (Ed.), Drugs and society: U.S. public policy (pp. 149–162). Lanham, MD: Rowman & Littlefield Publishers.
   Google Scholar
• Galaif, E. R., & Sussman, S. (1995). For whom does alcoholics anonymous work? International Journal of the Addictions, 30, 161–184.
   PubMed Web of Science ®Google Scholar
• Gottfredson, D. C., & Wilson, D. B. (2003). Characteristics of effective school-based substance abuse prevention. Prevention Science, 4(1), 27–38. doi:10.1023/A:1021782710278
   PubMedGoogle Scholar
• Gowing, L., Farrell, M., Borneman, R., Sullivan, L. E., & Ali, R. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews, 2, CD004145.
   PubMed Web of Science ®Google Scholar
• Grau, L. E., Dasgupta, N., Grau, L. E., Dasgupta, N., Harvey, A. P., Grau, L. E., … Grau, L. E. (2007). Illicit use of opioids: Is OxyContin a “gateway drug”? The American Journal on Addictions, 16, 166–173. doi:10.1080/10550490701375293
   PubMed Web of Science ®Google Scholar
• Grella, C. E., & Lovinger, K. (2011). 30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California. Drug Alcohol Depend, 118(2–3), 251–258. doi:10.1016/j.drugalcdep.2011.04.004
   PubMed Web of Science ®Google Scholar
• Grotenhermen, F., & Muller-Vahl, K. (2012). The therapeutic potential of cannabis and cannabinoids. Deutsches Ärzteblatt international, 109, 495–501. doi:10.3238/arztebl.2012.0495
   PubMed Web of Science ®Google Scholar
• Guise, A., Horyniak, D., Melo, J., McNeil, R., & Werb, D. (2017). The experience of initiating injection drug use and its social context: A qualitative systematic review and thematic synthesis. Addiction, 112, 2098–2111. doi:10.1111/add.13957
   PubMed Web of Science ®Google Scholar
• Guise, A., Melo, J., Mittal, M. L., Rafful, C., Cuevas-Mota, J., Davidson, P., … Werb, D. (2018). A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA. International Journal of Drug Policy, 55, 51–60. doi:10.1016/j.drugpo.2018.02.009 doi:10.1016/j.drugpo.2018.02.009
   PubMed Web of Science ®Google Scholar
• Guy Jr, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., … Dowell, D. (2017). Vital signs: changes in opioid prescribing in the United States, 2006–2015. MMWR. Morbidity and mortality weekly report, 66(26), 697.
   Google Scholar
• Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M., & Naber, D. (2007). Heroin-assisted treatment for opioid dependence: Randomised controlled trial. The British Journal of Psychiatry, 191(1), 55–62. doi:10.1192/bjp.bp.106.026112
   PubMedGoogle Scholar
• Hadland, S. E., Werb, D., Kerr, T., Fu, E., Wang, H., Montaner, J. S., & Wood, E. (2012). Childhood sexual abuse and risk for initiating injection drug use: A prospective cohort study. Preventive Medicine, 55, 500–504. doi:10.1016/j.ypmed.2012.08.015
   PubMed Web of Science ®Google Scholar
• Hassin, J. (1994). Living a responsible life: The impact of AIDS on the social identity of intravenous drug users. Social Science & Medicine, 39, 391–400.
   PubMed Web of Science ®Google Scholar
• Hays, L. R. (2004). A profile of oxycontin addiction. Journal of Addictive Diseases, 23, 1–9, doi:10.1300/J069v23n04_01
   PubMed Web of Science ®Google Scholar
• Hser, Y. I., Evans, E., Grella, C., Ling, W., & Anglin, D. (2015). Long-term course of opioid addiction. Harvard Review of Psychiatry, 23, 76–89. doi:10.1097/HRP.0000000000000052
   PubMed Web of Science ®Google Scholar
• International Narcotics Control Board: Report of the International Narcotics Control Board for 2017. 2017. New York: United Nations, 2018. Retrieved from https://www.incb.org/documents/Publications/AnnualReports/AR2017/Annual_Report_chapters/Chapter_2_2017.pdf
   Google Scholar
• Johnson, E. M., Lanier, W. A., Merrill, R. M., Crook, J., Porucznik, C. A., Rolfs, R. T., & Sauer, B. (2013). Unintentional prescription opioid-related overdose deaths: Description of decedents by next of kin or best contact, Utah, 2008–2009. Journal of General Internal Medicine, 28, 522–529. doi:10.1007/s11606-012-2225-z
   PubMed Web of Science ®Google Scholar
• Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2009). Monitoring the Future national survey results on drug use, 1975-2008. Volume I: Secondary school students (NIH Publication No. 09-7402; 721 pp.). Bethesda, MD: National Institute on Drug Abuse.
   Google Scholar
• Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2011). Monitoring the Future national results on adolescent drug use: Overview of key findings, 2010. Bethesda, MD: National Institute on Drug Abuse. Retrieved from http://monitoringthefuture.org/pubs/monographs/mtf-overview2010.pdf
   Google Scholar
• Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2013). Monitoring the Future national results on adolescent drug use: Overview of key findings, 2012. Bethesda, MD: National Institute on Drug Abuse.
   Google Scholar
• Jones, C. M. (2013). Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers–United States, 2002–2004 and 2008–2010. Drug & Alcohol Dependence, 132(1), 95–100. doi:10.1016/j.drugalcdep.2013.01.007
   PubMed Web of Science ®Google Scholar
• Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015a). National and state treatment need and capacity for opioid agonist medication-assisted treatment. American Journal of Public Health, 105, e55–e63. doi:10.2105/AJPH.2015.302664
   PubMed Web of Science ®Google Scholar
• Jones, C. M., Logan, J., Gladden, R. M., & Bohm, M. K. (2015b). Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013. MMWR Morbidity and Mortality Weekly Report, 64, 719–725.
   PubMed Web of Science ®Google Scholar
• Julien, R. M. (2005). A primer of drug action (9th ed.). New York, NY: W.H. Freeman and Company.
   Google Scholar
• Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36, 559–574. doi:10.1146/annurev-publhealth-031914-122957
   PubMed Web of Science ®Google Scholar
• Kral, A. H., Wenger, L., Novak, S. P., Chu, D., Corsi, K. F., Coffa, D., … Bluthenthal, R. N. (2015). Is cannabis use associated with less opioid use among people who inject drugs? Drug Alcohol Depend, 153, 236–241. doi:10.1016/j.drugalcdep.2015.05.014
   PubMed Web of Science ®Google Scholar
• Krebs, E. E., Gravely, A., Nugent, S., Jensen, A. C., DeRonne, B., Goldsmith, E. S., … Noorbaloochi, S. (2018). Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: The SPACE randomized clinical trial. JAMA, 319, 872–882. doi:10.1001/jama.2018.0899
   PubMed Web of Science ®Google Scholar
• Krupitsky, E., Zvartau, E., & Woody, G. (2010). Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available. Current Psychiatry Reports, 12, 448–453. doi:10.1007/s11920-010-0135-5
   PubMed Web of Science ®Google Scholar
• Lanier, W. A., Johnson, E. M., Rolfs, R. T., Friedrichs, M. D., & Grey, T. C. (2012). Risk factors for prescription opioid-related death, Utah, 2008-2009. Pain Medicine, 13, 1580–1589. doi:10.1111/j.1526-4637.2012.01518.x
   PubMed Web of Science ®Google Scholar
• Lee, J. S. J., Hu, H. M., Edelman, A. L., Brummett, C. M., Englesbe, M. J., Waljee, J. F., … Dossett, L. A. (2017). New persistent opioid use among patients with cancer after curative-intent surgery. Journal of Clinical Oncology, 35, 4042–4049. doi:10.1200/JCO.2017.74.1363
   PubMed Web of Science ®Google Scholar
• Ling, W., Mooney, L., & Hillhouse, M. (2011). Prescription opioid abuse, pain and addiction: Clinical issues and implications. Drug and Alcohol Review, 30, 300–305. doi:10.1111/j.1465-3362.2010.00271.x
   PubMed Web of Science ®Google Scholar
• Macleod, J., Hickman, M., Jones, H. E., Copeland, L., McKenzie, J., De Angelis, D., … Robertson, J. R. (2013). Early life influences on the risk of injecting drug use: Case control study based on the Edinburgh Addiction Cohort. Addiction, 108, 743–750. doi:10.1111/add.12056
   PubMed Web of Science ®Google Scholar
• Manchikanti, L., Kaye, A. M., Knezevic, N. N., McAnally, H., Slavin, K., Trescot, A. M., & Hirsch, J. (2017). Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician, 20, S3–S92.
   PubMed Web of Science ®Google Scholar
• Marie, B. S., Sahker, E., & Arndt, S. (2015). Referrals and treatment completion for prescription opioid admissions: Five years of national data. Journal of Substance Abuse Treatment, 59, 109–114. doi:10.1016/j.jsat.2015.07.010
   PubMed Web of Science ®Google Scholar
• Mars, S. G., Bourgois, P., Karandinos, G., Montero, F., & Ciccarone, D. (2014). “Every ‘never’I ever said came true”: Transitions from opioid pills to heroin injecting. International Journal of Drug Policy, 25, 257–266. doi:10.1016/j.drugpo.2013.10.004
   PubMed Web of Science ®Google Scholar
• Martin, F. S. (2010). Becoming vulnerable: Young women's accounts of initiation to injecting drug use. Addiction Research & Theory, 18, 511–527. doi:10.3109/16066351003611653
   Web of Science ®Google Scholar
• Martins, S. S., Sarvet, A., Santaella-Tenorio, J., Saha, T., Grant, B. F., & Hasin, D. S. (2017). Changes in US lifetime heroin use and heroin use disorder: Prevalence from the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry, 74, 445–455. doi:10.1001/jamapsychiatry.2017.0113
   PubMed Web of Science ®Google Scholar
• McCabe, S. E., West, B. T., Veliz, P., McCabe, V. V., Stoddard, S. A., & Boyd, C. J. (2017). Trends in medical and nonmedical use of prescription opioids among US adolescents: 1976–2015. Pediatrics, 139, e20162387.
   PubMed Web of Science ®Google Scholar
• McCauley, J. L., Back, S. E., & Brady, K. T. (2013). Pilot of a brief, web-based educational intervention targeting safe storage and disposal of prescription opioids. Addictive Behaviors, 38, 2230–2235. doi:10.1016/j.addbeh.2013.01.019
   PubMed Web of Science ®Google Scholar
• McLellan, A. T. (2002). Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction, 97(3), 249–252.
   Google Scholar
• Mohler-Kuo, M., Rehm, J., Heeb, J. L., & Gmel, G. (2004). Decreased taxation, spirits consumption and alcohol-related problems in Switzerland. Journal of Studies on Alcohol, 65, 266–273. doi:10.15288/jsa.2004.65.266
   PubMedGoogle Scholar
• National Academies of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: The National Academies Press. doi:10.17226/24625
   Google Scholar
• NIDA. (2018). Heroin. Retrieved from https://www.drugabuse.gov/publications/research-reports/heroin
   Google Scholar
• Novak, S. P., Bluthenthal, R., Wenger, L., Chu, D., & Kral, A. H. (2016). Initiation of heroin and prescription opioid pain relievers by birth cohort. American Journal of Public Health, 106, 298–300. doi:10.2105/AJPH.2015.302972
   PubMed Web of Science ®Google Scholar
• Noyes, R., Brunk, S. F., Avery, D. H., & Canter, A. (1975a). The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clinical Pharmacology and Therapeutics, 18(1), 84–89. doi:10.1002/cpt197518184
   PubMed Web of Science ®Google Scholar
• Office of Diversion Control Liaison and Policy Section Liaison Unit (ODLL), Drug Enforcement Administration. (2010). Information bulletin regarding a change in formulation for OxyContin tablets.
   Google Scholar
• Olson, M. E., & Janda, K. D. (2017). Vaccines to combat the opioid crisis: Vaccines that prevent opioids and other substances of abuse from entering the brain could effectively treat addiction and abuse. EMBO Reports, e201745322.
   Web of Science ®Google Scholar
• Oviedo-Joekes, E., Marchand, K., Guh, D., Marsh, D. C., Brissette, S., Krausz, M., … Schechter, M. T. (2011). History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment. Addictive Behaviors, 36(1–2), 55–60. doi:10.1016/j.addbeh.2010.08.020
   PubMed Web of Science ®Google Scholar
• Pagano, M. E., Friend, K. B., Tonigan, J. S., & Stout, R. L. (2004). Helping other alcoholics in alcoholics anonymous and drinking outcomes: Findings from project MATCH. Journal of Studies on Alcohol, 65, 766–773. doi:10.15288/jsa.2004.65.766
   PubMed Web of Science ®Google Scholar
• Pan, H., Gao, S., Grant, K., Novicoff, W., & Kang, H. (2018, April). Analyzing national and state opioid abuse treatment completion with multilevel modeling. Paper presented at the Systems and Information Engineering Design Symposium (SIEDS) (pp. 123–128). IEEE.
   Google Scholar
• PDMP Center of Excellence at Brandeis University. (2014). FL: Vital Signs Morbidity and Mortality Weekly Report, July 1, 2014.
   Google Scholar
• Peltz, G., & Südhof, T. C. (2018). The neurobiology of opioid addiction and the potential for prevention strategies. JAMA, 319, 2071–2072. doi:10.1001/jama.2018.3394
   PubMed Web of Science ®Google Scholar
• Pergolizzi, J., Aloisi, A. M., Dahan, A., Filitz, J., Langford, R., Likar, R., … Sacerdote, P. (2010). Current knowledge of buprenorphine and its unique pharmacological profile. Pain Practice, 10, 428–450. doi:10.1111/j.1533-2500.2010.00378.x
   PubMed Web of Science ®Google Scholar
• Posternak, V., Dunn, L. B., Dhruva, A., Paul, S. M., Luce, J., Mastick, J., … Miaskowski, C. (2016). Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of pain. Pain, 157, 892. doi:10.1097/j.pain.0000000000000456
   PubMed Web of Science ®Google Scholar
• Potier, C., Laprévote, V., Dubois-Arber, F., Cottencin, O., & Rolland, B. (2014). Supervised injection services: What has been demonstrated? A systematic literature review. Drug & Alcohol Dependence, 145, 48–68. doi:10.1016/j.drugalcdep.2014.10.012
   PubMed Web of Science ®Google Scholar
• Reifler, L. M., Droz, D., Bailey, J. E., Schnoll, S. H., Fant, R., Dart, R. C., & Bucher Bartelson, B. (2012). Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Medicine, 13, 434–442. doi:10.1111/j.1526-4637.2012.01327.x
   PubMed Web of Science ®Google Scholar
• Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal 6, 35. doi:10.1186/1477-7517-6-35
   PubMed Web of Science ®Google Scholar
• Rhodes, T. (1997). Risk theory in epidemic times: Sex, drugs and the social organisation of ‘risk behaviour’. Sociology of Health & Illness, 19, 208–227. doi:10.1111/1467-9566.ep10934410
   Web of Science ®Google Scholar
• Ricardo Buenaventura, M., Rajive Adlaka, M., & Nalini Sehgal, M. (2008). Opioid complications and side effects. Pain physician, 11, S105–S120.
   PubMed Web of Science ®Google Scholar
• Robson, P. (2001). Therapeutic aspects of cannabis and cannabinoids. The British Journal of Psychiatry, 178, 107–115.
   PubMed Web of Science ®Google Scholar
• Rosenbaum, M. (1979). Becoming addicted: The woman addict. Contemporary Drug Problems, 8, 141.
   Google Scholar
• Roy, É., Haley, N., Leclerc, P., Cédras, L., Blais, L., & Boivin, J. F. (2003). Drug injection among street youths in Montreal: Predictors of initiation. Journal of Urban Health, 80(1), 92–105. doi:10.1093/jurban/jtg092
   PubMed Web of Science ®Google Scholar
• Rutkow, L., Turner, L., Lucas, E., Hwang, C., & Alexander, G. C. (2015). Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. Health Affairs (Millwood), 34, 484–492. doi:10.1377/hlthaff.2014.1085
   PubMed Web of Science ®Google Scholar
• Saarto, T., & Wiffen, P. J. (2010). Antidepressants for neuropathic pain: A Cochrane review. Journal of Neurology, Neurosurgery & Psychiatry, 81(12), 1372–1373.
   PubMed Web of Science ®Google Scholar
• Salerno, S. M., Browning, R., & Jackson, J. L. (2002). The effect of antidepressant treatment on chronic back pain: A meta-analysis. Archives of Internal Medicine, 162(1), 19–24.
   PubMedGoogle Scholar
• Saxon, A. J., Oreskovich, M. R., & Brkanac, Z. (2005). Genetic determinants of addiction to opioids and cocaine. Harvard Review of Psychiatry, 13, 218–232. doi:10.1080/10673220500243364
   PubMed Web of Science ®Google Scholar
• Schindler, A., Thomasius, R., Petersen, K., & Sack, P. M. (2009). Heroin as an attachment substitute? Differences in attachment representations between opioid, ecstasy and cannabis abusers. Attachment & Human Development, 11, 307–330. doi:10.1080/14616730902815009
   PubMed Web of Science ®Google Scholar
• Seal, K. H., Thawley, R., Gee, L., Bamberger, J., Kral, A. H., Ciccarone, D., … Edlin, B. R. (2005). Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. Journal of Urban Health, 82, 303–311. doi:10.1093/jurban/jti053
   PubMed Web of Science ®Google Scholar
• Spoth, R., Trudeau, L., Shin, C., Ralston, E., Redmond, C., Greenberg, M., & Feinberg, M. (2013). Longitudinal effects of universal preventive intervention on prescription drug misuse: Three randomized controlled trials with late adolescents and young adults. American Journal of Public Health, 103, 665–672. doi:10.2105/AJPH.2012.301209
   PubMed Web of Science ®Google Scholar
• Staiger, T. O., Gaster, B., Sullivan, M. D., & Deyo, R. A. (2003). Systematic review of antidepressants in the treatment of chronic low back pain. Spine, 28, 2540–2545. doi:10.1097/01.BRS.0000092372.73527.BA
   PubMed Web of Science ®Google Scholar
• Strain, E. C. (2002). Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. Clinical Journal of Pain, 18, 514−527.
   Web of Science ®Google Scholar
• Strang, J., Grifiths, P., Powis, B., & Gossop, M. (1999). Heroin chasers and heroin injectors: Differences observed in a community sample in London, UK. The American Journal on Addictions, 8, 148–160.
   PubMed Web of Science ®Google Scholar
• Strike, C., Rotondi, M., Kolla, G., Roy, E., Rotondi, N. K., Rudzinski, K., … Hunt, N. (2014). Interrupting the social processes linked with initiation of injection drug use: Results from a pilot study. Drug Alcohol Depend, 137, 48–54. doi:10.1016/j.drugalcdep.2014.01.004
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2016). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2010). Office of Applied Studies, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS). Based on administrative data reported by States to TEDS through July 1, 2010. 2010. Available at: http://wwwdasis.samhsa.gov/webt/quicklink/US08.htm
   Google Scholar
• Sullivan, L. W., & Eagel, B. A. (2005). Leveling the playing field: Recognizing and rectifying disparities in management of pain. Pain Medicine, 6(1), 5–10. doi:10.1111/j.1526-4637.2005.05016.x
   PubMed Web of Science ®Google Scholar
• Sussman, S. Y. (2015). Evaluating the efficacy of Project TND: Evidence from seven research trials. In L. M. Scheier (Ed.), Handbook of adolescent drug use prevention: Research, intervention strategies, and practice (pp. 159–176). Washington, DC, US: American Psychological Association.
   Google Scholar
• Sussman, S. (2017). Substance and behavioral addictions: Concepts, causes, and cures. Cambridge University Press.
   Google Scholar
• Sussman, S., & Ames, S. L. (2008). Drug abuse: Concepts, prevention, and cessation. Cambridge University Press.
   Google Scholar
• Sussman, S., Rohrbach, L. A., Spruijt-Metz, D., Barnett, E., Lisha, N., & Sun, P. (2012). One-year prediction of pain killer use among at-risk older teens and emerging adults. Journal of Drug Education, 42, 195–210. doi:10.2190/DE.42.2.e
   PubMed Web of Science ®Google Scholar
• Tauras, J. A., Markowitz, S., & Cawley, J. (2005). Tobacco control policies and youth smoking: Evidence from a new era. In Substance use: Individual behaviour, social interactions, markets and politics (pp. 277–291). Emerald Group Publishing Limited.
   Google Scholar
• Tobler, N. S., & Stratton, H. H. (1997). Effectiveness of school-based drug prevention programs: A meta-analysis of the research. Journal of Primary Prevention, 18(1), 71–128. doi:10.1023/A:1024630205999
   Google Scholar
• Trenz, R. C., Scherer, M., Harrell, P., Zur, J., Sinha, A., & Latimer, W. (2012). Early onset of drug and polysubstance use as predictors of injection drug use among adult drug users. Addictive Behaviors, 37, 367–372. doi:10.1016/j.addbeh.2011.11.011
   PubMed Web of Science ®Google Scholar
• Unick, G. J., & Ciccarone, D. (2017). US regional and demographic differences inprescription opioid and heroin-related overdose hospitalizations. International Journal of Drug Policy, 46, 112–119.
   Google Scholar
• United Nations Office on Drugs and Crime, World Drug Report (UNODC). (2014). United Nations publication, Sales No. E.14.XI.7.
   Google Scholar
• U.S. Department of Health and Human Services, Center for Substance Abuse Treatment (CSAT). (2001). OxyContin: Prescription Drug Abuse. DHHS Publication No. (SMA)02-3636 NCADI Publication No. MS726. Washington, DC: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• van den Beuken-van, M. H., Hochstenbach, L. M., Joosten, E. A., Tjan-Heijnen, V. C., & Janssen, D. J. (2016). Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis. Journal of Pain and Symptom Management, 51, 1070–1090. doi:10.1016/j.jpainsymman.2015.12.340
   PubMed Web of Science ®Google Scholar
• Van Gundy, K. T. (2006). “Substance abuse in rural and small town America”. The Carsey School of Public Policy at the Scholars' Repository. 7. https://scholars.unh.edu/carsey/7
   Google Scholar
• Van Zee, A. (2009). The promotion and marketing of oxycontin: Commercial triumph, public health tragedy. American Journal of Public Health, 99, 221–227. doi:10.2105/AJPH.2007.131714
   PubMed Web of Science ®Google Scholar
• Verthein, U., Bonorden‐Kleij, K., Degkwitz, P., Dilg, C., Köhler, W. K., Passie, T., … Haasen, C. (2008). Long‐term effects of heroin‐assisted treatment in Germany. Addiction, 103, 960–966. doi:10.1111/j.1360-0443.2008.02185.x
   PubMed Web of Science ®Google Scholar
• Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., & van der Goes, D. N. (2015). Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain, 156, 569–576. doi:10.1097/01.j.pain.0000460357.01998.f1
   PubMed Web of Science ®Google Scholar
• Wang, J. C., Kapoor, M., & Goate, A. M. (2012). The genetics of substance dependence. Annual Review of Genomics and Human Genetics, 13, 241–261. doi:10.1146/annurev-genom-090711-163844
   PubMed Web of Science ®Google Scholar
• Ware, M. A.; Wang, T.; Shapiro, S.; Robinson, A.; Ducruet, T.; Huynh, T., … Collet, J.-P. (2010). Smoked cannabis for chronic neuropathic pain: A randomized controlled trial. Canadian Medical Association Journal, 182, 1–8.
   Web of Science ®Google Scholar
• Wenger, L. D., Lopez, A. M., Kral, A. H., & Bluthenthal, R. N. (2016). Moral ambivalence and the decision to initiate others into injection drug use: A qualitative study in two California cities. International Journal of Drug Policy, 37, 42–51. doi:10.1016/j.drugpo.2016.07.008
   PubMed Web of Science ®Google Scholar
• Werb, D., Bluthenthal, R. N., Kolla, G., Strike, C., Kral, A. H., Uuskula, A., & Des Jarlais, D. (2018). Preventing injection drug use initiation: State of the evidence and opportunities for the future. Journal of Urban Health, 95(1), 91–98. doi:10.1007/s11524-017-0192-8
   PubMed Web of Science ®Google Scholar
• Wheeler, E., Jones, T. S., Gilbert, M. K., Davidson, P. J., Centers for Disease Control and Prevention (CDC). (2015). Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. MMWR Morbidity and Mortality Weekly Report, 64, 631–635.
   Web of Science ®Google Scholar
• Wiffen, P. J., Wee, B., Derry, S., Bell, R. F., & Moore, R. A. (2017). Opioids for cancer pain-an overview of Cochrane reviews. Cochrane Database of Systematic Reviews. Chichester. UK: Wiley.
   Google Scholar
• Williams, A. C. D. C., Eccleston, C., & Morley, S. (2012). Psychological therapies for the management of chronic pain (excluding headache) in adults. The Cochrane Database of Systematic Reviews (11).
   Google Scholar
• Williams, A. V., Marsden, J., & Strang, J. (2014). Training family members to manage heroin overdose and administer naloxone: Randomized trial of effects on knowledge and attitudes. Addiction, 109, 250–259. doi:10.1111/add.12360
   PubMed Web of Science ®Google Scholar
• World Drug Report. (2018). United Nations publication, Sales No. E.18.XI.9.
   Google Scholar
• Young, A. M., Havens, J. R., & Leukefeld, C. G. (2012). A comparison of rural and urban nonmedical prescription opioid users’ lifetime and recent drug use. The American Journal of Drug and Alcohol Abuse, 38, 220–227. doi:10.3109/00952990.2011.643971
   PubMed Web of Science ®Google Scholar
• Young, A. M., Larian, N., & Havens, J. R. (2014). Gender differences in circumstances surrounding first injection experience of rural injection drug users in the United States. Drug & Alcohol Dependence, 134, 401–405. doi:10.1016/j.drugalcdep.2013.10.013
   PubMed Web of Science ®Google Scholar
• Zacny, J. P. (1995). A review of the effects of opioids on psychomotor and cognitive functioning in humans. Experimental and Clinical Psychopharmacology, 3, 432–466. doi:10.1037/1064-1297.3.4.432
   Web of Science ®Google Scholar
• Zacny, J. P., & Lichtor, S. A. (2008). Nonmedical use of prescription opioids: Motive and ubiquity issues. The Journal of Pain, 9, 473–486. doi:10.1016/j.jpain.2007.12.008
   PubMed Web of Science ®Google Scholar